Medication for Addiction Treatment in Correctional Settings
a FACT SHEET by the Legislative Analysis and Public Policy Association

Through the use of medications for addiction treatment (MAT), an individual’s substance use, withdrawal symptoms, and the physiological and psychological cravings can be controlled, enabling the person to begin treatment while in a correctional facility and be released as a person in, or on his or her way to, recovery. Research shows that that the use of MAT for Opioid Use Disorder in correctional settings is a cost-effective and life-saving intervention.

Please note that Section 1262 of the Consolidated Appropriations Act, 2023 removes the federal requirement for practitioners to submit a Notice of Intent (have a waiver) to prescribe medications, like buprenorphine, for the treatment of opioid use disorder (OUD).

Click here to read the full Fact Sheet.